Section of Cardiovascular Pharmacotherapy
The Section of Cardiovascular Pharmacotherapy
was established in 1983 in the Department of Pharmacy Practice at the College of Pharmacy. Members of the Section
hold academic appointments in both the College of Pharmacy and the College of Medicine (Section of Cardiology,
Department of Medicine) at UIC. They are responsible for research and scholarly activities relating to the clinical use,
safety and efficacy of drugs used for cardiovascular disease. Members are also responsible for instruction to pharmacy,
medical and nursing students and collaborative clinical pharmacy practice in a variety of specialty areas within cardiology. |
Director: Jerry L. Bauman,
PharmD, FCCP, FACC, Professor, Departments of Pharmacy Practice and Medicine (Cardiology);
Head, Department of Pharmacy Practice |
|
Larisa Cavallari, PharmD,
Assistant Professor |
|
Robert DiDomenico, PharmD,
Clinical Assistant Professor |
|
Vicki Groo, PharmD,
Clinical Assistant Professor |
|
Edith Nutescu, PPharmD,
Clinical Associate Professor and Director, Antithrombosis Center |
|
Marieke D. Schoen, PharmD,
Clinical Associate Professor |
EXAMPLES OF RECENT PAPERS:
Humma LM, Puckett
BJ, Richardson HE, et al. Effects of beta-1 adrenoceptor genetic polymorphisms
on resting hemodynamics in patients undergoing diagnostic testing for ischemia.
American Journal of Cardiology 2001;88:1034-7. |
Schoen MD, DiDomenico
RJ, Connor SE, et al. Impact of the cost of prescription drugs on clinical
outcomes in indigent patients with heart disease. Pharmacotherapy 2001;21:1455-63. |
Southworth MR,
Zarembski D, Viana M, Bauman JL. Comparison of sotalol versus quinidine for
maintenance of normal sinus rhythm in patients with chronic atrial fibrillation.
American Journal of Cardiology 1999;83:1629-32. |
Sanoski CA, Bauman
JL. Clinical observations with the amiodarone-warfarin interaction: dosing
relationships with long-term therapy. Chest 2002;121:19-23. |
|
DiDomenico RJ,
Sanoski CA, Walton S, Bauman JL. Analysis of the use of digoxin immune Fab
for the treatment of non-life threatening digoxin toxicity. Journal of
Cardiovascular Pharmacology and Therapeutics 2000;5:77-85. |
Schumock GT,
Nutescu EA, Walton SM, Arondekar BV, Lewis RK. Survey of hospital practices
rregarding low-molecular weight heparins. American Journal of Health System
Pharmacy 2002;59:534-8. |
Wang J, Moughy
EB, David CJ, Humma LM, et al. Determination of human B2-adrenoceptor haplotypes
by denaturation selective amplification and subtractive genotyping. American
Journal of Pharmacogenomics 2001;1:315-322. |
|
Bauman JL. The
role of pharmacokinetics, pharmacogenomics and drug interactions in the acquired
long QT syndrome. European Journal of Cardiology 2001;3:K93-100. |
Bauman JL, DiDomenico
RJ. Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms
of sudden cardiac death. Journal of Cardiovascular Pharmacology and Therapeutics
(in press).
|
|
1983-84 Rick A. Barbarash, PharmD, FCCP |
|
1984-85 Bruce J. Schrader, PharmD, FCCP |
|
1985-86 Steven I. Berk, PharmD, MD |
|
1986-88 Nada S. Berry, PharmD |
|
1987-89 Patrick L. McCollam, PharmD |
|
1987-89 Robert B. Parker, PharmD, FCCP |
|
1988-89 Vicky L. Just, PharmD |
|
1988-90 Marieke D. Schoen, PharmD |
|
1989-90 Jon E. Folstad, PharmD |
|
1990-92 Deborah Tworek Piscitelli, PharmD |
|
1990-93 Sheila A. Roberts, PharmD |
|
1991-93 Jeffrey J. Grawe, PharmD |
|
1991-93 Allison P. Winecoff, PharmD |
|
1992-94 Kristin C. Oberg, PharmD |
|
1993-95 Bradley G. Phillips, PharmD |
|
1994-96 Ashesh J. Gandhi, PharmD |
|
1996-97 Mary Ross Southworth, PharmD |
|
1996-98 Cynthia A. Sanoski, PharmD |
|
1997-99 Robert J. DiDomenico, PharmD |
|
2001-02 Maria Tanzi, PharmD |
PAST STUDENTS AND GENERAL RESIDENTS:
|
1983-85 |
Mark Munger, PharmD, FCCP |
|
1984-86 |
Tim Hoon, PharmD |
|
1988-90 |
Eric Stanek, PharmD |
|
1992-93 |
Dawn Bell, PharmD |
|
1995 |
Dawn Zaremski Donna Leslie Lynette Moser |